Prestige Brand Holdings (PBH) Stock Price, Quote & News

Company Profile

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name;...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 914 524 6800

Website: www.prestigebrands.com

Address:

660 White Plains Road, Tarrytown, United States

OfficialStocktwitsUser Jan. 16 at 3:19 AM

$PBH RSI: 66.91, MACD: 1.0240 Vol: 1.27, MA20: 63.08, MA50: 61.28 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZacksResearch Jan. 2 at 11:39 AM

Is now the moment to add $PBH to your portfolio — or wait it out? 🤔 Prestige Consumer Healthcare is riding e-commerce momentum, strategic acquisitions, and solid solvency, but inflation and tariff costs are creating near-term pressure investors can’t ignore. ⚠️ Get the full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2811195/is-this-the-right-time-to-add-pbh-stock-to-your-portfolio?cid=sm-stocktwits-2-2811195-teaser-27077&ADID=SYND_STOCKTWITS_TWEET_2_2811195_TEASER_27077

0 · Reply

BillionerOfKing Dec. 29 at 1:07 PM

$PBH Current Stock Price: $62.85 Contracts to trade: $65 PBH Jan 16 2026 Call Entry: $0.41 Exit: $0.78 ROI: 93% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

WebWave Dec. 26 at 6:21 AM

$PBH The thesis is evolving from vision-led to process-driven as scrutiny intensifies. Execution gaps should narrow meaningfully. Clear evidence of resilience would lower perceived risk. Patience is sensible — but only if matched by progress.

0 · Reply

BillionerOfKing Dec. 11 at 6:06 PM

$PBH Current Stock Price: $61.22 Contracts to trade: $60 PBH Jan 16 2026 Call Entry: $0.10 Exit: $0.17 ROI: 65% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

TimRegan_WTR Nov. 18 at 6:32 PM

$PBH

0 · Reply

JarvisFlow Nov. 7 at 9:57 PM

Canaccord Genuity has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Buy with a target price of 100 → 88.

0 · Reply

BillionerOfKing Nov. 7 at 2:14 PM

$PBH Current Stock Price: $61.40 Contracts to trade: $60 PBH Nov 21 2025 Call Entry: $3.54 Exit: $6.53 ROI: 85% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Estimize Nov. 6 at 11:00 AM

$PBH reported - EPS and - revenue for Q2. http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_content=PBH&utm_medium=act

0 · Reply

Estimize Nov. 4 at 11:03 PM

Wall St is expecting 0.97 EPS for $PBH Q2 [Reporting 11/06 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

0 · Reply

Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference

Nov 10, 2025, 4:31 PM EST - 2 months ago

Premium Brands Holdings Corporation (PBH:CA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:36 PM EST - 3 months ago

Prestige Consumer Healthcare Inc. (PBH) Q2 2026 Earnings Call Transcript

Nov 6, 2025, 6:00 AM EST - 3 months ago

Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results

Oct 29, 2025, 9:59 AM EDT - 3 months ago

Q3 2025 Improving Fundamentals Position Portfolio For Upside

BRC MSTR MTRN PHIN

Oct 6, 2025, 5:00 PM EDT - 4 months ago

Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results

Sep 5, 2025, 1:17 AM EDT - 5 months ago

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript

Sep 4, 2025, 7:00 AM EDT - 5 months ago

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

Aug 8, 2025, 2:39 AM EDT - 6 months ago

Prestige Consumer Healthcare Inc. (PBH) Q1 2026 Earnings Call Transcript

Aug 7, 2025, 6:00 AM EDT - 6 months ago

Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results

Jul 15, 2025, 8:00 AM EDT - 7 months ago

Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results

Jun 17, 2025, 5:38 PM EDT - 8 months ago

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination

Jun 9, 2025, 4:30 PM EDT - 8 months ago

Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference

May 11, 2025, 6:53 AM EDT - 9 months ago

Prestige Consumer Healthcare Inc. (PBH) Q4 2025 Earnings Call Transcript

May 8, 2025, 7:09 AM EDT - 9 months ago

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

May 8, 2025, 6:00 AM EDT - 9 months ago

Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

Apr 10, 2025, 5:00 PM EDT - 10 months ago

Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results

Feb 6, 2025, 11:02 AM EST - 1 year ago

Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 6:00 AM EST - 1 year ago

Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook

Nov 9, 2024, 11:50 AM EST - 1 year ago

Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Transcript

Aug 8, 2024, 11:20 AM EDT - 1 year ago

Prestige Consumer Healthcare Inc. (PBH) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 6:00 AM EDT - 1 year ago

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results

Jul 2, 2024, 4:30 PM EDT - 1 year ago

Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results

May 15, 2024, 1:15 PM EDT - 1 year ago

Prestige Consumer Healthcare Inc (PBH) Q4 2024 Earnings Call Transcript

May 14, 2024, 5:00 PM EDT - 1 year ago

Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results

Apr 25, 2024, 8:30 AM EDT - 1 year ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results

Apr 3, 2024, 11:57 AM EDT - 1 year ago

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

Feb 8, 2024, 2:18 PM EST - 2 years ago

Prestige Consumer Healthcare Inc. (PBH) Q3 2024 Earnings Call Transcript

Feb 8, 2024, 6:00 AM EST - 2 years ago

Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

Feb 2, 2024, 9:00 AM EST - 2 years ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

Jan 10, 2024, 5:00 PM EST - 2 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results

Dec 22, 2023, 9:00 AM EST - 2 years ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

Nov 24, 2023, 8:30 AM EST - 2 years ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

Nov 2, 2023, 6:00 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results

Oct 5, 2023, 4:30 PM EDT - 2 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results

Aug 5, 2023, 8:53 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. (PBH) Q1 2024 Earnings Call Transcript

Aug 3, 2023, 6:00 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results

Jul 11, 2023, 8:00 AM EDT - 2 years ago

Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results

Jul 6, 2023, 4:30 PM EDT - 2 years ago

Prestige Consumer Healthcare Publishes Inaugural Sustainability Report

Jun 5, 2023, 9:00 AM EDT - 2 years ago

Prestige Consumer Healthcare to Present at Upcoming Investor Conferences

May 31, 2023, 9:00 AM EDT - 2 years ago

Goody's® Introduces New “GET TO GOOD™” Marketing Campaign

May 23, 2023, 2:00 PM EDT - 2 years ago

Dramamine® Eases Americans' Travel Woes with ‘Ditch the Drama' Sweepstakes Offering a Vacation to Anywhere in the World

May 4, 2023, 6:00 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023

Feb 2, 2023, 11:49 AM EST - 3 years ago

Prestige Consumer Healthcare Inc. (PBH) Q3 2023 Earnings Call Transcript

Feb 2, 2023, 6:00 AM EST - 3 years ago

Prestige Consumer Healthcare Inc. Reports Third Quarter Results

Jan 5, 2023, 4:30 PM EST - 3 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Third Quarter Earnings Results

Nov 6, 2022, 3:55 AM EST - 3 years ago

Prestige Consumer Healthcare Inc. (PBH) Q2 2023 Earnings Call Transcript

Nov 5, 2022, 3:59 PM EDT - 3 years ago

Premium Brands Holdings Corporation (PRBZF) Q3 2022 Earnings Call Transcript

Nov 3, 2022, 6:00 AM EDT - 3 years ago

Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023

Oct 4, 2022, 4:30 PM EDT - 3 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Second Quarter Earnings Results

OfficialStocktwitsUser Jan. 16 at 3:19 AM

0 · Reply

ZacksResearch Jan. 2 at 11:39 AM

0 · Reply

BillionerOfKing Dec. 29 at 1:07 PM

0 · Reply

WebWave Dec. 26 at 6:21 AM

0 · Reply

BillionerOfKing Dec. 11 at 6:06 PM

0 · Reply

TimRegan_WTR Nov. 18 at 6:32 PM

$PBH

0 · Reply

JarvisFlow Nov. 7 at 9:57 PM

Canaccord Genuity has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Buy with a target price of 100 → 88.

0 · Reply

BillionerOfKing Nov. 7 at 2:14 PM

0 · Reply

Estimize Nov. 6 at 11:00 AM

$PBH reported - EPS and - revenue for Q2. http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_content=PBH&utm_medium=act

0 · Reply

Estimize Nov. 4 at 11:03 PM

Wall St is expecting 0.97 EPS for $PBH Q2 [Reporting 11/06 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

0 · Reply

JarvisFlow Oct. 21 at 1:36 PM

Oppenheimer has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Outperform with a target price of 82 → 72.

0 · Reply

TheDailyDirtnap Oct. 5 at 4:30 PM

$PBH Consumer products consistency. Steady uptrend intact. Low volatility institutional holding. Relative strength.

0 · Reply

Sidoti Sep. 18 at 8:13 PM

Prestige Consumer Healthcare Inc. ($PBH) Management Team presented today at the Sidoti Small-Cap Virtual Conference. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_eeOvc7BATUuTCaJFlyxGfg

0 · Reply

NVDAMillionaire Sep. 9 at 6:36 AM

$PBH Really good write-up that perfectly summarizes PBH's present situation. So if you want to bring your PBH knowledge up to date or just discover PBH, this is required reading. https://beyondspx.com/quote/PBH/analysis/prestige-consumer-healthcare-fortifying-its-niche-amidst-supply-headwinds-and-strategic-acquisitions-nyse-pbh

0 · Reply

Mohamed209 Aug. 13 at 9:37 PM

$PBH what’s going on here ?

0 · Reply

Mohamed209 Aug. 13 at 9:36 PM

$PBH 👀

0 · Reply

TimRegan_WTR Aug. 13 at 4:57 PM

$PBH

0 · Reply

JarvisFlow Aug. 8 at 10:00 PM

Canaccord Genuity has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Buy with a target price of 105 → 100.

0 · Reply

Lavaman76 Jul. 16 at 1:20 PM

$PBH Got into PBH - way oversold and looking for run-up into earnings. https://schrts.co/ruacehbJ

0 · Reply

Estimize Jul. 2 at 8:00 PM

Wall St is expecting 1.00 EPS for $PBH Q1 [Reporting 07/31 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

0 · Reply

Market Cap	3.07B
Revenue (ttm)	1.14B
Net Income (ttm)	214.61M
EPS (ttm)	N/A
PE Ratio	13.85
Forward PE	13.88
Profit Margin	18.86%
Debt to Equity Ratio	0.54

Volume	406,600
Avg Vol	405,004
Day's Range	N/A - N/A
Shares Out	48.08M
Stochastic %K	31%
Beta	0.40
Analysts	Strong Sell
Price Target	$76.67